MRGBP: A New Factor for Diagnosis and Prediction of Head and Neck Squamous Cell Carcinoma

Table 2

MRGBP expression associated with clinicopathological characteristics (logistic regression).

Characteristics	Total ()	Odds ratio (OR)	value
Age (>60 vs. ≤60)	499	0.858 (0.604-1.220)	0.394
Gender (male vs. female)	500	1.825 (1.222-2.745)	0.004
Clinical stage (stage III and stage IV vs. stage I and stage II)	486	1.290 (0.847-1.971)	0.237
T stage (T3 and T4 vs. T1 and T2)	485	1.508 (1.040-2.193)	0.031
N stage (N2 and N3 vs. N0 and N1)	478	1.099 (0.751-1.609)	0.627
M stage (M1 vs. M0)	475	0.252 (0.013-1.720)	0.219
Radiation therapy (yes vs. no)	439	0.962 (0.649-1.424)	0.845
Primary therapy outcome (PR and CR vs. PD and SD)	416	0.745 (0.401-1.368)	0.343
Histologic grade (G3 and G4 vs. G1 and G2)	481	1.387 (0.918-2.105)	0.122
Smoker (yes vs. no)	490	1.666 (1.087-2.574)	0.020